• Users Online: 217
  • Print this page
  • Email this page
Year : 2021  |  Volume : 59  |  Issue : 4  |  Page : 404-406

Reversible blurred vision with hydroxychloroquine in a COVID-19 patient

1 Department of Pharmacology, Dr. D Y Patil Medical College, Navi Mumbai, Maharashtra, India
2 MGM School of Physiotherapy, Navi Mumbai, Maharashtra, India

Correspondence Address:
Dr. Pramila Yadav
Department of Pharmacology, Dr D Y Patil Medical College, Nerul, Navi Mumbai, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/tjosr.tjosr_165_20

Get Permissions

Among the umbrella of drugs postulated for COVID-19 treatment, chloroquine and hydroxychloroquine (HCQ) are currently being used in the management of COVID-19–positive patients in India. Hydroxychloroquine (HCQ) retinopathy is a known but a rare adverse effect when used in autoimmune diseases. However, advanced age, comorbidities (such as diabetes, obesity and cardiovascular disease), and patients taking subsequent comedications could be potentially more susceptible. We present a unique case history of patient suffering from reversible blurred vision probably due to HCQ in a COVID-19 patient.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded11    
    Comments [Add]    

Recommend this journal